Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo

Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo

Jing Wang,1 Shuting Zuo,1 Yan Zhang,1 Shanzhi Li,2 Ying Shi,1 Tonghua Du,1 Jicheng Han,2 Ningyi Jin,2– 4 Yiquan Li,2 Xiao Li2,3 1Department of Breast Surgery, The Second Hospital of Jilin University, Changchun, 130000, People’s Republic of China; 2Academician Workstation of Jilin Province, Changchun...

Full description

Bibliographic Details
Main Authors: Wang J, Zuo S, Zhang Y, Li S, Shi Y, Du T, Han J, Jin N, Li Y, Li X
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Cancer Management and Research
Subjects:
cyclophosphamide
recombinant adenovirus
breast cancer
synergy
toxicity
Online Access:https://www.dovepress.com/recombinant-oncolytic-adenovirus-combined-with-cyclophosphamide-induce-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/recombinant-oncolytic-adenovirus-combined-with-cyclophosphamide-induce-peer-reviewed-fulltext-article-CMAR

Similar Items